Davis WalpFounder

United States - Greater Boston

Davis Walp, founder and CEO of CuriMeta, brings more than 25 years experience across lifesciences manufacturer, professional services, and health information technology segments. With a background in executive leadership and general management of healthtech startups spanning precision medicine, RWE data analytics, clinical/observational research, and patient engagement, Davis will ensure CuriMeta invests in and creates best-in-class real-world, anonymized health data and research solutions to improve healthcare for all.

Prior to founding CuriMeta, Davis was an executive leader at Decision Resources Group (now part of Clarivate), a global products and professional services business focused on providing health analytics, insights, and consulting services. Davis also has held leadership roles at Veradigm where he was responsible for general management of research offerings to CROs and pharmaceutical sponsors, Allscripts, where he led precision medicine strategy and partnership development, and ConvergeHEALTH by Deloitte, where he was responsible for product and customer strategy, client delivery, and collaborative research solutions. Davis also spent over a decade at Johnson & Johnson, Pfizer, and GlaxoSmithKline in strategic marketing, new product planning, and corporate development roles.

Davis holds a MBA from the William E. Simon Graduate School of Business Administration at the University of Rochester.